Heartlink Limited

Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics

Older News

PERTH, Australia, August 16, 2011 - Australian based Heartlink Limited is developing proprietary synthetic compounds based on the isoflavone structure that have demonstrated anti-cancer efficacy in both laboratory and animal studies at low dosage levels.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy